# Prestwick Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prestwick-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Washington, US
- Total disclosed funding: $82M
- Latest round: Series C (Jul 21, 2006)
- Investors on record: 8

## About

Prestwick Pharmaceuticals, Inc. is based in Washington, US and develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases.

## Funding rounds

- Series C, Jul 21, 2006, $30M — Atlas Venture, Sofinnova Investments, Warburg Pincus, Scale Venture Partners, Vivo Capital, FirstMark Capital, CNF Investments
- Series B, Dec 6, 2004, $37M — Atlas Venture, Sofinnova Investments, Scale Venture Partners, Vivo Capital, FirstMark Capital, CNF Investments
- Series A, Jun 19, 2003, $15M — Atlas Venture, Sofinnova Investments, BioAsia Investments, Scale Venture Partners

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series A, Series B, Series C
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A, Series B, Series C
- BioAsia Investments (https://capitalatlas.ai/funds/bioasia-investments) — Series A
- Scale Venture Partners (https://capitalatlas.ai/funds/scale-venture-partners) — Series A, Series B, Series C
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series B, Series C
- FirstMark Capital (https://capitalatlas.ai/funds/firstmark-capital) — Series B, Series C
- CNF Investments (https://capitalatlas.ai/funds/cnf-investments) — Series B, Series C
- Warburg Pincus (https://capitalatlas.ai/funds/warburg-pincus) — Series C
